Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxime. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111138345A reveals a solvent-free iron-catalyzed route for polysubstituted pyridines, offering significant cost reduction and scalability for API manufacturing.
Novel preparation method for 4'-epidaunorubicin intermediate ensures high purity and stability. Optimized for commercial scale-up and cost reduction in pharmaceutical manufacturing.
Patent CN112279779B details a mild copper-catalyzed asymmetric oxime etherification. Discover high-ee pharmaceutical intermediates and cost-effective manufacturing solutions.
Advanced synthesis of 3-(7-amidino-2-naphthyl) derivatives via amidoxime reduction. Superior optical purity and scalable manufacturing for reliable API intermediate supply.
Novel one-pot synthesis for high-purity oxime chelators. Enhanced metal binding for pharma and metallurgy applications with simplified processing.
Novel fluorine-modified catalyst method for 2-pentanone oxime. High purity, scalable process for silicone cross-linkers. Reliable supply chain partner.
Patent CN109180407A reveals a novel aldoxime dehydration route. This technology offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110698393A discloses a metal-free radical relay method using fluorinated oxime ethers for efficient drug intermediate synthesis, offering significant cost reduction and supply chain reliability.
Patent CN101274915A details a low-cost iodine-catalyzed oxidation route for isoxazoles, offering significant supply chain advantages.
Patent CN101613263B details a novel MnO2 oxidation route for carvone. Achieve >99% purity with simplified workflow and reduced environmental impact for flavor industries.
Novel catalytic hydrogenation process for high-purity 2-amino-2-arylethanols using Raney nickel. Offers significant cost reduction and scalability for pharmaceutical intermediates.
Novel cesium-catalyzed route for 7-AMCA ensures high purity and yield. Optimize supply chain for cefpodoxime proxetil intermediate manufacturing with safer chemistry.
Patent CN112500311A reveals a novel benzophenone-mediated synthesis for O-3-chloro-2-propenyl hydroxylamine, offering >98% purity and recyclable reagents for clethodim production.
Advanced catalytic reduction route for Rivastigmine Tartrate offering high purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN105949217A reveals TEMPO oxidation for milbemycin oxime intermediate. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and scalable supply.
Patent CN111072515B reveals a green continuous flow method for cephalosporin intermediates, offering significant cost reduction and supply chain stability for global pharma manufacturers.
Advanced preparation method for high-purity cefuroxime acid using ternary solvent extraction. Achieves >99% purity for antibiotic manufacturing with optimized supply chain efficiency.
Patent CN115322116B details a green synthesis of nitriles from aldoximes using a stable solid promoter, offering cost reduction and safer supply chains for pharmaceutical intermediates.
Novel visible-light method for beta-aminocarbonyls using oxalyl oxime esters. High yield, mild conditions. Cost-effective pharma intermediate manufacturing solution.
Patent CN104447396B details a novel Pd-catalyzed route for benzoin oxime derivatives, offering safer alternatives to cyanide methods and enhanced supply chain reliability for pharmaceutical intermediates.